We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+9.41%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$36.7B
AUM Growth
+$3.15B
(+9.4%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
5.15%
Holding
3,891
New
644
Increased
1,079
Reduced
1,381
Closed
771
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$159M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$156M |
| 3 |
Intel
INTC
|
+$140M |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$125M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$168M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$160M |
| 3 |
Meta Platforms (Facebook)
META
|
+$147M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$142M |
| 5 |
Baidu
BIDU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.13% |
| 2 | Consumer Discretionary | 12.6% |
| 3 | Industrials | 10.86% |
| 4 | Healthcare | 10.49% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Vitamin Cottage Natural Grocers
NGVC
$651M
| $1.37M | ﹤0.01% |
81,121
+12,929
| +19% | +$215K |
|
1752
PUT
NetEase
NTES
$82.5B
| $1.37M | ﹤0.01% |
30,000
-72,500
| -71% | -$3.33M |
|
1753
CALL
Prudential Financial
PRU
$41.5B
| $1.37M | ﹤0.01% |
13,500
-10,500
| -44% | -$1.04M |
|
1754
eHealth
EHTH
$38.4M
| $1.37M | ﹤0.01% |
48,351
+36,700
| +315% | +$974K |
|
1755
Freeport-McMoran
FCX
$115B
| $1.36M | ﹤0.01% |
+98,054
| New | +$1.48M |
|
1756
CALL
Thor Industries
THO
$4.14B
| $1.36M | ﹤0.01% |
16,300
+7,800
| +92% | +$746K |
|
|
SREV
1757
DELISTED
ServiceSource International, Inc.
SREV
| $1.36M | ﹤0.01% |
477,232
-56,246
| -11% | -$187K |
|
|
SOHU
1758
Sohu.com
SOHU
$374M
| $1.36M | ﹤0.01% |
68,370
+52,815
| +340% | +$1.34M |
|
|
CISN
1759
DELISTED
Cision Ltd. Ordinary Share
CISN
| $1.36M | ﹤0.01% |
80,809
-95,912
| -54% | -$1.58M |
|
1760
PUT
Prologis
PLD
$136B
| $1.36M | ﹤0.01% |
20,000
-29,800
| -60% | -$1.96M |
|
1761
Franklin Templeton
BEN
$17.8B
| $1.35M | ﹤0.01% |
44,573
+22,925
| +106% | +$739K |
|
1762
Johnson Outdoors
JOUT
$479M
| $1.35M | ﹤0.01% |
14,574
+6,044
| +71% | +$564K |
|
1763
PUT
Teva Pharmaceuticals
TEVA
$44.4B
| $1.35M | ﹤0.01% |
62,900
-21,400
| -25% | -$497K |
|
1764
PUT
Humana
HUM
$46.8B
| $1.35M | ﹤0.01% |
4,000
-9,000
| -69% | -$2.92M |
|
|
FLIC
1765
DELISTED
First of Long Island Corp
FLIC
| $1.35M | ﹤0.01% |
62,215
-1,664
| -3% | -$38K |
|
1766
PUT
Medifast
MED
$136M
| $1.35M | ﹤0.01% |
+6,100
| New | +$1.24M |
|
1767
Green Brick Partners
GRBK
$3.16B
| $1.35M | ﹤0.01% |
+133,662
| New | +$1.34M |
|
1768
Adeia
ADEA
$2.99B
| $1.35M | ﹤0.01% |
343,485
-61,852
| -15% | -$263K |
|
|
ABMD
1769
CALL
DELISTED
Abiomed Inc
ABMD
| $1.35M | ﹤0.01% |
3,000
+1,000
| +50% | +$394K |
|
|
AXON
1770
CALL
Axon Enterprise
AXON
$49.8B
| $1.35M | ﹤0.01% |
19,700
+11,400
| +137% | +$769K |
|
|
CSR
1771
Centerspace
CSR
$905M
| $1.35M | ﹤0.01% |
22,540
+15,604
| +225% | +$858K |
|
|
CNH
1772
CNH Industrial
CNH
$18.6B
| $1.35M | ﹤0.01% |
128,935
-225,962
| -64% | -$2.25M |
|
1773
CALL
Ball Corp
BALL
$17B
| $1.34M | ﹤0.01% |
30,500
+12,900
| +73% | +$525K |
|
|
SP
1774
DELISTED
SP Plus Corporation
SP
| $1.34M | ﹤0.01% |
36,761
-10,923
| -23% | -$421K |
|
1775
CALL
Omega Healthcare
OHI
$14.2B
| $1.34M | ﹤0.01% |
40,900
-25,600
| -38% | -$815K |
|
Similar funds
John Overdeck's Q3 2018 Portfolio in Review
As of Q3 2018, John Overdeck held 3,891 positions worth $36.7B, up 9.4% from $33.5B the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
John Overdeck's Q3 2018 filing shows 644 new, 1,079 increased, 1,381 reduced and 771 closed positions. Its largest new stake was Royal Caribbean: 1,011,770 shares worth $131M. The largest sale was Burlington, an estimated $168M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.
- John Overdeck's largest Q3 2018 buy was Royal Caribbean: 1,011,770 shares worth $131M.
- John Overdeck added most to Boeing in Q3 2018, an estimated $159M increase.
- John Overdeck's biggest Q3 2018 reduction was Burlington, cutting an estimated $168M.
- John Overdeck fully exited Align Technology in Q3 2018, selling an estimated $116M.
- John Overdeck's ten largest holdings make up 5.1% of its $36.7B portfolio in Q3 2018.
- John Overdeck opened 644 new positions and closed 771 in Q3 2018.
- John Overdeck's portfolio value rose 9.4% quarter-over-quarter to $36.7B.
Based on Two Sigma Investments's 13F filing for Q3 2018, filed 14 Nov 2018.